Transplant Genomics, Inc.
Clinical trials sponsored by Transplant Genomics, Inc., explained in plain language.
-
New blood tests aim to spot early kidney transplant trouble
Disease control Not yet recruitingThis study is testing two blood tests (TruGraf and TRAC) to see if they can help doctors better monitor kidney transplant patients. The tests look for early signs of organ rejection or other problems, which could help doctors adjust anti-rejection medications sooner. The study wi…
Sponsor: Transplant Genomics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New blood test aims to catch dangerous viruses before they damage transplanted kidneys
Disease control Not yet recruitingThis study follows 1,000 kidney transplant patients for one year to see if monthly blood tests can detect dangerous viruses early enough to prevent complications. Researchers will track CMV and BK virus levels along with other immune markers to identify patients at risk before th…
Sponsor: Transplant Genomics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC